Orrick, Herrington & Sutcliffe LLP

03/05/2026 | Press release | Distributed by Public on 03/05/2026 08:58

Amicus Brief on Behalf of Leading Pharmaceutical Innovators Urges Federal Court to Invalidate CMS Drug Price Negotiation Guidance

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
Orrick, Herrington & Sutcliffe LLP published this content on March 05, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on March 05, 2026 at 14:58 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]